The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday:** London-listed drugmaker Shire Plc said it was ready to recommend a new 31 billion pounds ($53 billion) takeover offer from AbbVie Inc, entering talks after receiving a fifth bid from the U.S. firm.** Generic drugmaker Mylan Inc said it would purchase Abbott Laboratories' specialty and branded generics business in developed markets outside the United States in an all-stock transaction valued at about $5.3 billion.
AbbVie Inc. (AbbVie) is a research-based pharmaceuticals company. Shares of ABBV fell by 0.92% or $-0.505/share to $54.46. In the past year, the shares have traded as low as $42.25 and as high as $58.27. On average, 5832730 shares of ABBV exchange hands on a given day and today's volume is recorded at 5971551.
Mylan Inc. (Mylan) is a fully integrated global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Shares of MYL traded higher by 3.27% or $1.64/share to $51.84. In the past year, the shares have traded as low as $31.64 and as high as $57.52. On average, 4053860 shares of MYL exchange hands on a given day and today's volume is recorded at 4424889.
Source
